The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Disease relapse represents by far the most frequent cause of hematopoietic cell transplantation (HCT) failure. Patients with acute leukemia suffering relapse after HCT have limited conventional treatment options with little possibility of cure and represent, de facto, suitable candidates for the eva...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2022-11-01
|
| シリーズ: | Frontiers in Oncology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1066285/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
